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Prediction of Cancer Incidence and Mortality in Korea, 2015
Special Article
Purpose
For estimation of Korea’s current cancer burden, this study aimed to report on the projected
cancer incidence and mortality rates for the year 2015.
Materials and Methods
Cancer incidence data from 1999 to 2012 were obtained from the Korea National Cancer
Incidence Database, and cancer mortality data from 1993 to 2013 were acquired from 
Statistics Korea. The cancer incidence in 2015 was projected by fitting a linear regression
model to the observed age-specific cancer incidence rates against the observed years and
then multiplying the projected age-specific rates by the age-specific population. A similar
procedure was used for cancer mortality, except a Joinpoint regression model was used to
determine at which year the linear trend changed significantly.
Results
A total of 280,556 new cancer cases and 76,698 cancer deaths are expected to occur in
Korea in 2015. The crude incidence rate per 100,000 of all sites combined will likely reach
551.6 and the age-standardized incidence rate, 347.6. The estimated five leading primary
cancer incidence sites are the stomach, colorectum, lung, prostate, and liver in men; and
thyroid, breast, colorectum, stomach, and lung in women. The projected crude mortality
rate of all sites combined and age-standardized rate is 150.8 and 82.4, respectively.
Conclusion
Cancer is currently one of the foremost public health concerns in Korea, and as the popu-
lation ages, the nation’s cancer burden will continue to increase.
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Introduction
As the leading cause of death in Korea [1], cancer has been
the country’s major public health concern since 1983. Over
210,000 patients were newly diagnosed with cancer in Korea,
and one in four deaths is due to cancer [2]. Although the 
cancer registration system in Korea is highly efficient and can
provide nationwide cancer statistics within a relatively brief
period, a lag time of at least 2 years is required for collection,
compilation, and analysis of the data on a specific year. For
planning and implementation of comprehensive cancer 
control programs, it is important to assess the number of new
cases and deaths that are expected to occur during the 
current year. In this study, we report the projected cancer 
incidence and mortality for the year 2015 based on data from
the 1990s through 2013.
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Materials and Methods
The Korean Ministry of Health and Welfare initiated a 
nationwide, hospital-based cancer registry, the Korea Central
Cancer Registry (KCCR), in 1980. The history, objectives, and
activities of the KCCR have been documented in detail else-
where [3]. Incidence data from 1999 to 2012 were obtained
from the Korea National Cancer Incidence Database (KNCI
DB). Cancer cases were classified according to the Interna-
tional Classification of Diseases for Oncology, third edition
[4], and converted according to the International Classifica-
tion of Diseases, 10th edition (ICD-10) [5]. Mortality data
from 1993 to 2013 were acquired from Statistics Korea [1].
The causes of death were coded and classified according to
ICD-10 [5].
The cancer sites included in this study were (1) all cancers
combined and (2) the 24 common cancers as follows: lip, oral
cavity, and pharynx (C00-C14), esophagus (C15), stomach
(C16), colon and rectum (C18-C20), liver and intrahepatic bile
ducts (liver) (C22), gallbladder and other parts of the biliary
tract (gallbladder) (C23-C24), pancreas (C25), larynx (C32),
lung and bronchus (lung) (C33-C34), breast (C50), cervix
uteri (C53), corpus uteri (C54), ovary (C56), prostate (C61),
testis (C62), kidney (C64), bladder (C67), brain and central
nervous system (C70-C72), thyroid (C73), Hodgkin lym-
phoma (C81), non-Hodgkin lymphoma (C82-C85, C96), mul-
tiple myeloma (C90), leukemia (C91-C95), and others.
Population data from 1993 to 2014 were obtained from the
resident registration population, as reported by Statistics
Korea. Data on the mid-year population, as of July 1 of the
respective years, were analyzed. However, for the year 2015,
we used population data as of December 31, 2014 because
the mid-2015 resident registration population was not yet
available at the time of analysis.
Due to the time required for data collection, compilation,
quality control, and analysis, the incidence and mortality
data for a specific year are usually available 2-3 years later.
Site
Estimated new cases Estimated deaths
Both Male Female Both Male Female
All sites 280,556 137,747 142,809 76,698 47,527 29,171
Lip, oral cavity, and pharynx 3,176 2,339 837 1,062 780 282 
Esophagus 2,362 2,161 201 1,214 1,136 78 
Stomach 35,053 23,917 11,136 7,516 4,806 2,710 
Colon and rectum 38,038 23,493 14,545 9,018 5,209 3,809 
Liver 17,310 12,744 4,566 10,812 7,996 2,816 
Gallbladdera) 6,034 3,024 3,010 4,023 1,940 2,083 
Pancreas 6,313 3,383 2,930 5,374 2,812 2,562 
Larynx 1,049 1,019 30 365 359 6 
Lung 25,640 17,673 7,967 17,559 12,736 4,823 
Breast 19,540 75 19,465 2,385 18 2,367 
Cervix uteri 3,100 - 3,100 761 - 761 
Corpus uteri 2,429 - 2,429 288 - 288 
Ovary 2,374 - 2,374 1,075 - 1,075 
Prostate 14,828 14,828 - 1,840 1,840 -
Testis 248 248 - 19 19 -
Kidney 5,212 3,599 1,613 1,031 713 318 
Bladder 4,245 3,419 826 1,390 1,061 329 
Brain and CNS 1,891 1,016 875 1,127 596 531 
Thyroid 65,829 11,338 54,491 384 116 268 
Hodgkin lymphoma 298 192 106 62 42 20 
Non-Hodgkin lymphoma 5,319 2,918 2,401 1,651 955 696 
Multiple myeloma 1,490 806 684 911 497 414 
Leukemia 3,141 1,770 1,371 1,767 1,025 742 
Other and ill-defined 15,637 7,785 7,852 5,064 2,871 2,193 
CNS, central nervous system. a)Includes the gallbladder and other/unspecified parts of the biliary tract. 
Table 1. Estimated new cancer cases and deaths by sex during 2015 in Korea
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Therefore, to provide an estimate of the nation’s current 
cancer burden, we attempted to project, ahead of 2015, the
expected number of new cancer cases and deaths in Korea
for the year. Linear regression models [6] were used to assess
time trends and projections. Based on the observed cancer
incidence data from 1999 to 2012, a linear regression model
was fitted to age-specific rates by 5-year age groups against
the observed years. The estimated number of new cancer
cases was calculated from the projected age-specific rates for
2015 by multiplying the rates by the projected 2015 age-
specific population size. For thyroid and prostate cancer,
which showed significant curvilinear trends, we used a
square-root transformation when fitting a linear regression
model and converted the predicted values back to the origi-
nal scale. 
To predict the cancer mortality rate in 2015, we first 
performed a Joinpoint regression analysis on the data avail-
able for 1993-2013 to determine the year when significant
changes occurred in cancer mortality trends according to sex
and cancer site. A Joinpoint regression describes changes in
data trends by connecting several different line segments on
a log scale at “joinpoints.” This analysis was performed using
the Joinpoint software (ver. 4.0.1, http://surveillance.can-
cer.gov/joinpoint) from the Surveillance Research Program
of the US National Cancer Institute [7]. 
After identifying the year during which significant trend
changes occurred through Joinpoint regression analysis, 
a simple linear regression model was fitted to the last line
segment for estimation of age-specific cancer mortality rates
in 2015. Similar to the method used for the projection of 
cancer incidence, the number of new deaths in 2015 was then
predicted by multiplying age-specific cancer mortality rates
by the year’s age-specific population. 
We summarized the results using crude rates (CRs) 
and age-standardized rates (ASRs) of cancer incidence and
mortality. ASRs were standardized using the world standard
population [8] and expressed per 100,000 persons.
Results
1. Incidence
A total of 280,556 new cancer cases are anticipated in 2015
(Table 1, Fig. 1) with more female (n=142,809) than male
(n=137,747) cancer patients expected in the coming year. 
The projected CRs per 100,000 of all sites combined in 2015
are 541.9 and 561.3 in men and women, respectively. More-
over, the projected ASRs per 100,000 of all sites combined are
361.1 and 353.1, respectively (Table 2). In men, the five lead-
ing primary sites of cancer are expected to be the stomach
(CR, 94.1; ASR, 61.3), colon and rectum (CR, 92.4; ASR, 60.7),
lung (CR, 69.5; ASR, 44.7), prostate (CR, 58.3; ASR, 38.1), and
liver (CR, 50.1; ASR, 32.6), accounting for 67.3% of all newly
diagnosed cancers in 2015. In women, the five leading 
primary sites are expected to be the thyroid (CR, 214.2; ASR,
150.4), breast (CR, 76.5; ASR, 50.5), colon and rectum (CR,
57.2; ASR, 31.0), stomach (CR, 43.8; ASR, 24.3), and lung (CR,
31.3; ASR, 15.8), accounting for 75.3% of all newly diagnosed
cancers (Fig. 1). Thyroid cancer alone is projected to account
for approximately 38.2% (54,491 cases) of incident cases in
women in 2015.
The five most common cancer sites expected in 2015 by sex
and age group are shown in Table 3. Leukemia and thyroid
cancer are expected to be the most common forms of cancer






































































































Fig. 1. The 10 leading types of estimated new cancer cases and deaths by sex in 2015. (A) Estimated new cases. (B) Estimated deaths.
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cancer is predicted to be the most prevalent in men aged 
35-64 years, whereas lung cancer is expected to be more 
frequent in men aged 65 and over. Thyroid cancer is 
predicted to be the most common cancer in women 35-64
years of age, whereas colorectal cancer is expected to be the
most prevalent in women aged 65 and over. These projec-
tions indicate that the incidences of stomach, lung, liver, 
colorectal, and prostate cancers will increase gradually with
age for men. In women, the age-specific incidence rates of
stomach, colorectal, liver, lung, and cervical cancers denote
a rising trend in these cancers with age; however, the inci-
dence of breast and thyroid cancer in women is expected to
level off after the late 40s and early 50s, respectively (Fig. 2).
2. Mortality
It is estimated that 76,698 cancer deaths will occur in Korea
during 2015 (Table 1, Fig. 1). The projected CRs per 100,000
of all sites combined in 2015 for men and women are 187.0
and 114.6, respectively, whereas the projected ASRs per
100,000 of all sites combined are 121.7 and 54.5, respectively
(Table 4). The predicted five leading cancer sites causing
mortality in men are lung (CR, 50.1; ASR, 31.9), liver (CR,
31.5; ASR, 20.4), colon and rectum (CR, 20.5; ASR, 13.4),
stomach (CR, 18.9; ASR, 12.2), and pancreas (CR, 11.1; ASR,
7.2). During the same time period, lung cancer (CR, 19.0;
ASR, 8.5) is projected to be the leading cancer site in women,
causing mortality, followed by the colon and rectum (CR,
15.0; ASR, 6.6), liver (CR, 11.1; ASR, 5.2), stomach (CR, 10.7;
ASR, 4.7), and pancreas (CR, 10.1; ASR, 4.5). As a result of a
continuous decrease in stomach cancer deaths, stomach was
first predicted to be the fourth-common cancer death site in
women.
The predicted age-specific mortality rates of the selected
cancers for males and females in 2015 are shown in further
detail in Fig. 3. When examined by age, Korean men and
Crude incidence rate Age-standardized incidence rate
Site per 100,000 per 100,000a)
Both Male Female Both Male Female
All sites 551.6 541.9 561.3 347.6 361.1 353.1
Lip, oral cavity, and pharynx 6.2 9.2 3.3 4.0 6.1 2.1 
Esophagus 4.6 8.5 0.8 2.7 5.5 0.4 
Stomach 68.9 94.1 43.8 41.3 61.3 24.3 
Colon and rectum 74.8 92.4 57.2 44.7 60.7 31.0 
Liver 34.0 50.1 17.9 20.4 32.6 9.5 
Gallbladderb) 11.9 11.9 11.8 6.5 7.8 5.5 
Pancreas 12.4 13.3 11.5 7.0 8.7 5.6 
Larynx 2.1 4.0 0.1 1.2 2.6 0.1 
Lung 50.4 69.5 31.3 28.2 44.7 15.8 
Breast 38.4 0.3 76.5 25.4 0.2 50.5 
Cervix uteri 6.1 - 12.2 4.0 - 7.8 
Corpus uteri 4.8 - 9.5 3.1 - 6.2 
Ovary 4.7 - 9.3 3.2 - 6.2 
Prostate 29.2 58.3 - 16.9 38.1 -
Testis 0.5 1.0 - 0.5 1.0 -
Kidney 10.2 14.2 6.3 6.5 9.5 3.9 
Bladder 8.3 13.5 3.2 4.6 8.7 1.5 
Brain and CNS 3.7 4.0 3.4 3.0 3.4 2.6 
Thyroid 129.4 44.6 214.2 90.4 31.2 150.4 
Hodgkin lymphoma 0.6 0.8 0.4 0.5 0.7 0.4 
Non-Hodgkin lymphoma 10.5 11.5 9.4 7.2 8.4 6.2 
Multiple myeloma 2.9 3.2 2.7 1.7 2.1 1.5 
Leukemia 6.2 7.0 5.4 5.3 6.2 4.4 
Other and ill-defined 30.7 30.6 30.9 19.4 21.7 17.4 
CNS, central nervous system. a)Age adjusted to the world standard population, b)Includes the gallbladder and other/unspec-
ified parts of the biliary tract.
Table 2. Estimated crude and age-standardized cancer incidences by sex during 2015 in Korea
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Rank
Age group (yr)
0-14 15-34 35-64 ≥ 65
Male
1 Leukemia Thyroid Stomach Lung
(5.2) (19.5) (102.9) (469.3)
2 Brain and CNS Colon and rectum Colon and rectum Stomach
(2.5) (3.4) (99.1) (433.1)
3 Non-Hodgkin lymphoma Leukemia Thyroid Colon and rectum
(2.4) (3.3) (74.7) (430.3)
4 Kidney Non-Hodgkin lymphoma Liver Prostate
(0.6) (3.3) (61.6) (412.1)
5 Liver Stomach Lung Liver
(0.4) (2.2) (42.6) (200.6)
Female
1 Leukemia Thyroid Thyroid Colon and rectum
(4.1) (96.9) (372.0) (215.0)
2 Brain and CNS Breast Breast Stomach
(1.9) (11.9) (137.0) (155.4)
3 Non-Hodgkin lymphoma Cervix uteri Colon and rectum Lung
(1.5) (5.4) (54.4) (136.5)
4 Ovary Stomach Stomach Thyroid
(0.9) (3.7) (43.8) (132.4)
5 Thyroid Ovary Lung Liver
(0.8) (3.0) (24.3) (77.4)
CNS, central nervous system.































































































































Fig. 2. Projected age-specific incidences of major cancers during 2015 in Korea. (A) Male. (B) Female.
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women aged 60 and over are expected to have the highest
mortality rates from lung cancer.
Conclusion
A total of 280,556 new cancer cases and 76,698 cancer
deaths are expected to occur in Korea during 2015. In Korean
males, it is anticipated that stomach, colorectal, lung,
prostate, and liver cancers will be the most commonly occur-
ring, whereas it is expected that lung, liver, colorectal, stom-
ach, and pancreatic cancers will be the most common causes
of cancer-related deaths. In Korean women, it is anticipated
that thyroid, breast, colorectal, stomach, and lung cancers
will be the most prevalent, whereas it is projected that lung,
colorectal, liver, stomach, and pancreatic cancers will be the
most common causes of cancer-related deaths.
Cancer is currently one of the foremost public health 
concerns in Korea. The country will likely see its cancer 
burden continue to grow with the aging of its population.
The current projections of cancer incidence and mortality for
2015 represent an important resource for planning and eval-
uation of cancer-control programs. As the estimates in this
study are model-based, these results should be interpreted
with caution.
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Crude mortality rate Age-standardized mortality rate
Site per 100,000 per 100,000a)
Both Male Female Both Male Female
All sites 150.8 187.0 114.6 82.4 121.7 54.5
Lip, oral cavity, and pharynx 2.1 3.1 1.1 1.2 2.0 0.6 
Esophagus 2.4 4.5 0.3 1.3 2.8 0.1 
Stomach 14.8 18.9 10.7 7.8 12.2 4.7 
Colon and rectum 17.7 20.5 15.0 9.5 13.4 6.6 
Liver 21.3 31.5 11.1 12.2 20.4 5.2 
Gallbladderb) 7.9 7.6 8.2 4.0 4.9 3.4 
Pancreas 10.6 11.1 10.1 5.7 7.2 4.5 
Larynx 0.7 1.4 0.0 0.4 0.9 0.0 
Lung 34.5 50.1 19.0 18.2 31.9 8.5 
Breast 4.7 0.1 9.3 2.9 0.0 5.6 
Cervix uteri 1.5 - 3.0 0.9 - 1.6 
Corpus uteri 0.6 - 1.1 0.3 - 0.6 
Ovary 2.1 - 4.2 1.2 - 2.3 
Prostate 3.6 7.2 - 1.7 4.8 -
Testis 0.0 0.1 - 0.0 0.1 -
Kidney 2.0 2.8 1.2 1.1 1.8 0.6 
Bladder 2.7 4.2 1.3 1.3 2.8 0.5 
Brain and CNS 2.2 2.3 2.1 1.6 1.8 1.3 
Thyroid 0.8 0.5 1.1 0.4 0.3 0.4 
Hodgkin lymphoma 0.1 0.2 0.1 0.1 0.1 0.0 
Non-Hodgkin lymphoma 3.2 3.8 2.7 1.8 2.5 1.3 
Multiple myeloma 1.8 2.0 1.6 1.0 1.3 0.8 
Leukemia 3.5 4.0 2.9 2.2 2.9 1.7 
Other and ill-defined 10.0 11.3 8.6 5.5 7.5 4.1 
CNS, central nervous system. a)Age adjusted to the world standard population, b)Includes the gallbladder and other/unspec-
ified parts of the biliary tract.
Table 4. Estimated crude and age-standardized cancer mortality rates by sex during 2015 in Korea
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Fig. 3. Projected age-specific mortality rates of major cancers during 2015 in Korea. (A) Male. (B) Female.
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